Ariez Publishing
Listen to Dr. Kevin Punie and Prof. Evandro de Azambuja discussing the key results of the phase III Olympia study, evaluating adjuvant olaparib in patients with BRCA-mutant early breast cancer
00:00 / 13:10
Advertisement